FindTrial
Sign In

Effect of intralipid on natural killer cells' abnormal activity-induced recurrent pregnant loss

effect of intralipid on natural killer cells' abnormal activity-induced recurrent pregnant loss

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001992
Enrollment
Unknown
Registered
2011-12-17
Start date
2010-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent pregnant loss

Interventions

A:intralipid
B:IVIG

Sponsors

The memorial hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 43 Years

Inclusion criteria

Inclusion criteria: 1. spontaneous abortions >=2 times (with the same person); 2. 20~43 years old; 3. CD56+CD16+ concentration >18%.

Exclusion criteria

Exclusion criteria: 1. exclude other high risk factors, which can induce RPL; 2. exclude other surgical and internal diseases; 3. exclude medicine user whose medicine use can influence NK activity, such as predinison and IVIG.

Design outcomes

Primary

MeasureTime frame
NK cytotoxicit;—

Countries

China

Contacts

Public ContactZhang Jianping
zjp2570@126.com+86 13902262443

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026